Evidence map›Paper›PMID 33436863›Full record

ArticleScientific reports2021

Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.

Alexandros Lalos, Ali Tülek, Nadia Tosti, Robert Mechera, Alexander Wilhelm, Savas Soysal, Silvio Daester, Venkatesh Kancherla, Benjamin Weixler, Giulio C Spagnoli and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Role of Microbiota-Derived Metabolites in Colorectal Cancer.International journal of molecular sciences · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Alexandros LalosUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland. alexandroslalos7@gmail.com.
Ali TülekUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland.
Nadia TostiInstitute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland.
Robert MecheraUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland.
Alexander WilhelmUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland.
Savas SoysalUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland.
Silvio DaesterUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland.
Venkatesh KancherlaInstitute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland.
Benjamin WeixlerDepartment of Surgery, Charité University Hospital, Campus Benjamin Franklin, Berlin, Germany.
Giulio C SpagnoliDepartment of Biomedicine, University Hospital Basel, Basel, Switzerland.
Serenella Eppenberger-CastoriInstitute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland.
Luigi TerraccianoInstitute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland.
Salvatore PiscuoglioInstitute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland.
Markus von FlüeUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland.
Alberto PosabellaUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland.
Raoul A DroeserUniversity Center for Gastrointestinal and Liver Diseases, Clarunis, University of Basel, Basel, Switzerland. RaoulAndre.Droeser@clarunis.ch.
University of Basel · CHUniversity Hospital of Basel · CHCharité - Universitätsmedizin Berlin · DERoyal Prince Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since colorectal cancer (CRC) remains one of the most common malignancies, a tremendous amount of studies keep taking place in this field. Over the past 25 years, a notable part of the scientific community has focused on the association between the immune system and colorectal cancer. A variety of studies have shown that high densities of infiltrating CD8+ T-cells are associated with improved disease-free and overall survival in CRC. Stromal cell-derived factor-1 (SDF-1) is a protein that regulates leukocyte trafficking and is variably expressed in several healthy and malignant tissues. There is strong evidence that SDF-1 has a negative prognostic impact on a variety of solid tumors. However, the existing data do not provide sufficient evidence that the expression of SDF-1 has an influence on CRC. Knowing nowadays, that the microenvironment plays a crucial role in the development of cancer, we hypothesized that the expression of SDF-1 in CRC could influence the prognostic significance of CD8+ T-cells, as an indicator of the essential role of the immune microenvironment in cancer development. Therefore, we explored the combined prognostic significance of CD8+ T-cell density and SDF-1 expression in a large CRC collective. We analyzed a tissue microarray of 613 patient specimens of primary CRCs by immunohistochemistry (IHC) for the CD8 + T-cells density and the expression of SDF-1 by tumor cells and tumor-infiltrating immune cells. Besides, we analyzed the expression of SDF-1 at the RNA level in The Cancer Genome Atlas cohort. We found that the combined high CD8+ T-cell infiltration and expression of SDF-1 shows a favorable 5-year overall survival rate (66%; 95% CI 48-79%) compared to tumors showing a high expression of CD8+ T-cell only (55%; 95% CI 45-64%; p = 0.0004). After stratifying the patients in nodal negative and positive groups, we found that the prognostic significance of CD8+ T-cell density in nodal positive colorectal cancer depends on SDF-1 expression. Univariate and multivariate Hazard Cox regression survival analysis considering the combination of both markers revealed that the combined high expression of SDF-1 and CD8+ T-cell density was an independent, favorable, prognostic marker for overall survival (HR = 0.34, 95% CI 0.17-0.66; p = 0.002 and HR = 0.45, 95% CI 0.23-0.89; p = 0.021, respectively). In our cohort there was a very weak correlation between SDF-1 and CD8+ T-cells (r

Indexed as

AdultAgedAged, 80 and overCD8-Positive T-LymphocytesChemokine CXCL12Cohort StudiesColorectal NeoplasmsDatabases, GeneticFemaleHumansMaleMiddle AgedNeoplasm StagingPrognosisSurvival RateTumor MicroenvironmentChemokine CXCL12CXCL12 protein, human

Identifiers

PMID33436863
PMCPMC7803998
OpenAlexW3119199219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.